1 / 4

European Metered Dose Inhaler Market Growth, Size, Share and Forecast 2019-2025

The European metered dose inhaler market was valued at around $2.4 billion in 2018 and is anticipated to grow at a substantial rate of 2.8% during the forecast period. Major countries that will contribute to the metered dose inhaler market within the region includes UK, Germany, France, Italy, and Spain.

shriram01
Télécharger la présentation

European Metered Dose Inhaler Market Growth, Size, Share and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research European Metered Dose Inhaler Market Share, Trends, Size, Research and Forecast 2019-2025 Request a free sample of our report on European Metered Dose Inhaler Market: https://www.omrglobal.com/request-sample/european-metered-dose-inhaler-market ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. The European metered dose inhaler market was valued at around $2.4 billion in 2018 and is anticipated to grow at a substantial rate of 2.8% during the forecast period. Major countries that will contribute to the metered dose inhaler market within the region includes UK, Germany, France, Italy, and Spain. A significant number of companies, research, patient base has been observed in the market due to which a significant growth can be observed in the market. According to the International Monetary Fund (IMF), Europe is home to around 740 million people and the GDP of the European Union is $19.7 trillion in 2017. As per Organization for Economic Co-operation and Development (OECD), the self-reported asthma rate and COPD rate by European Union countries were 6.1% and 4.0% respectively and it has been found out that the rate of prevalence of diseases are higher in women as compared to men. This is expected to drive the regional business growth of the metered dose inhaler market. A https://www.omrglobal.com/industry-reports/european-metered-dose-inhaler-market full report of European Metered Dose Inhaler Market is available at: The European metered dose inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhaler are analyzed. The preventive metered dose inhaler segment led the global Metered Dose Inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/european-metered-dose-inhaler-market Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing metered dose inhalers to cater to a wide range of customers within the region and across the globe. The major players of the European Metered Dose Inhaler market include Boehringer Ingelheim International GmbH, AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Teva Pharmaceuticals Industries Ltd., Koninklijke Philips N.V., and Bespak. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.

  3. European Metered Dose Inhaler Market- Segmentation By Type Preventive Inhaler Reliever Inhaler Long Acting Bronchodilators Inhaler By Application Asthma Chronic Obstructive Pulmonary Disease (COPD) By End-User Homecare Hospitals and Clinics For more customized data, request for report customization @ https://www.omrglobal.com/report- customization/european-metered-dose-inhaler-market European Metered Dose Inhaler Market– Segment by Region UK Germany France Italy Spain Rest of Europe Company Profiles 3M Co. Acorda Therapeutics, Inc. Adamis Pharmaceuticals Corp. Adherium Ltd. AstraZeneca PLC Bespak Boehringer Ingelheim International GmbH Chiesi Farmaceutici S.P.A.

  4. GF Health GlaxoSmithKline PLC H&T Presspart Manufacturing Ltd. Koninklijke Philips N.V. Novartis AG Omron Healthcare Inc. ResMed Corp. Pulmatrix Inc. Savara, Inc. Teicos Pharma Ltd. Teva Pharmaceuticals Industries Ltd. Vitalograph Ltd. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

More Related